Indeed, CML cells take advantage of their own growth by inducing BMSCs to upregulate PlGF, which in turn promotes CML proliferation, in part independently of BCR-ABL1+ signaling. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.